Filing Details
- Accession Number:
- 0001209191-17-041385
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-22 16:29:42
- Reporting Period:
- 2017-06-20
- Filing Date:
- 2017-06-22
- Accepted Time:
- 2017-06-22 16:29:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1673776 | H Steven Stein | 1801 Augustine Cut-Off Wilmington DE 19803 | Evp & Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-06-20 | 3,870 | $95.76 | 18,518 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2017-06-20 | 6,013 | $88.68 | 24,531 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-06-20 | 3,870 | $125.00 | 20,661 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-06-20 | 6,013 | $125.00 | 14,648 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-06-20 | 3,870 | $0.00 | 3,870 | $95.76 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-06-20 | 6,013 | $0.00 | 6,013 | $88.68 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
9,392 | 2023-01-06 | No | 4 | M | Direct | |
9,878 | 2022-03-01 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- This includes an 14,648 aggregate of shares of common stock issuable pursuant to previously reported restricted stock units that have not vested
- Beginning January 7, 2016, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years
- Beginning March 2, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.